Comparing two treatments for glaucoma with cataract
Official title: Efficacy of Phacogoniotomy in Medically-controlled Primary Open-angle Glaucoma With Cataract a Multicenter Non-inferiority Randomized Controlled Trial
Run by Sun Yat-sen University · NCT06201455 · Data updated 2026-11-12
This study is testing whether a new surgery for glaucoma combined with cataract removal works as well as the usual surgery plus eye drops for people with both conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | September 28, 2023 |
| Main results expected | September 30, 2026 |
| Study ends | December 31, 2029 |
| Registry record updated | December 11, 2024 |
| Trial ID | NCT06201455 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40 to 85 diagnosed with medically-controlled primary open-angle glaucoma and cataract.
✕Probably not a fit
Patients with a history of intraocular surgery, other types of glaucoma, or severe ocular diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized controlled trial aims to evaluate the effectiveness of phacoemulsification with goniotomy (PEI+GT) versus phacoemulsification with medical therapy (PEI+MED) in patients with medically-controlled primary open-angle glaucoma (POAG) and cataract. Participants will be randomly assigned to receive either treatment and will be followed for one year to assess intraocular pressure reduction and health economics. The study seeks to determine if the minimally invasive approach of PEI+GT is as effective as the traditional medical therapy while potentially offering benefits in terms of recovery and complications.
Why it matters
Potential benefit: If successful, this study could provide a less invasive treatment option for patients with glaucoma and cataract, reducing their reliance on medication.
How similar studies have gone: Previous studies have shown promising results for minimally invasive glaucoma surgeries, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 40 ≤ Age ≤ 85 years, gender unrestricted. 2. Diagnosed with POAG. 3. Controlled IOP under 1 to 4 topical hypotensive medications, IOP ≤ 24 mmHg 4. Mean deviation (MD) for perimetry ≥ -16dB. 5. Presence of clinically significant cataract and best-corrected visual acuity measured using the ETDRS chart ≤ 0.63. 6. Voluntary participation of the patient in this study, signing an informed consent form, and agreeing to follow-up visits according to the study protocol. Exclusion Criteria: 1. Any history of intraocular surgery or ocular trauma. 2. Presence of other types of glaucoma, including primary angle-closure glaucoma and various forms of secondary glaucoma (e.g. secondary angle-closure, pigmentary, steroid-induced, angle-recession, neovascular, inflammatory, and pseudoexfoliation syndrome). 3. Presence of severe ocular diseases of various types that affect the acquisition of ocular parameters or interfere with perimetry. 4. Axial length \> 28 mm. 5. Monophthalmia (best-corrected visual acuity of the non-study eye \< 0.01). 6. Coexistence of severe systemic diseases affecting the entire body. 7. Pregnant or lactating women. * If both eyes of a patient meet the criteria, the eye with worse visual acuity will be selected for inclusion.
Where it's running
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Xiulan Zhang, MD. PhD
- Email: zhangxl2@mail.sysu.edu.cn
- Phone: +86 13570166308
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Slow-coagulation trans-scleral cyclophotocoagulation versus trabeculectomy with mitomycin C for uncontrolled open-angle glaucoma after cataract surgery
This trial will test whether slow-coagulation trans-scleral cyclophotocoagulation or trabeculectomy with mitomycin C better lowers eye pressure in people over 40 with pseudophakic open-angle glaucoma not controlled by medications.
-
Virtual reality visual field testing for people with open-angle glaucoma
This will test whether a virtual reality visual field test can match the standard Humphrey Field Analyzer for people with open‑angle glaucoma.
-
Evaluating the safety and effectiveness of iDose TR with cataract surgery
This study is testing if adding the iDose TR implant during cataract surgery can safely lower eye pressure better than just having cataract surgery alone for people with glaucoma or high eye pressure.
-
Electrical stimulation to improve vision in glaucoma
This trial will test whether a noninvasive transorbital alternating current stimulation device (EYETRONIC rtACS) can improve vision in adults with moderate open-angle glaucoma.
-
Observing changes in the eye's drainage angle after surgery
This study looks at how different eye surgeries can help people with glaucoma by checking the changes in their eye drainage angle after the procedures.
-
Comparing Hydrus Microstent and Goniotomy for Glaucoma Treatment
This study is testing whether the Hydrus Microstent works better than goniotomy for lowering eye pressure in people with mild to moderate glaucoma who are also having cataract surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.